Published in Drug Law Weekly, November 14th, 2006
"We evaluated Botox injection into the urethral urinary sphincter in children with non-neurogenic neurogenic bladder to decrease urethral resistance and improve voiding. In these patients alpha-blocker medications had failed and injection was an alternative to unavailable biofeedback. Prospective treatment was performed in 10 children 6 to 17 years old (mean age 8) with non-neurogenic neurogenic bladder using Botox," researchers in Egypt report.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.